Showing results (891-900 of 904) with videos related to
Sort By:
Pageof 91
Frontiers in Immunology|August 28, 2025
Patient-derived colorectal microtumors predict response to anti-PD-1 therapyDuy T Nguyen, Matthew A Schaller, Krista P Terracina, et al.Environmental Toxicology and Chemistry|September 30, 2021
Method Development for a Short-Term 7-Day Toxicity Test with Unionid MusselsNing Wang, James L Kunz, Douglas K Hardesty, et al.The Journal of Allergy and Clinical Immunology|March 12, 2025
A novel dominant-negative variant of IRF8 in a mother and son: Clinical, phenotypic and biological characteristicsHyoungjun Ham, Crescent R Isham, Elizabeth H Ristagno, et al.Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formationDaniel P Walker, F Christopher Bi, Amit S Kalgutkar, et al.Journal of the Endocrine Society|July 14, 2021
Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years' Experience in the UKFederica Buonocore, Avinaash Maharaj, Younus Qamar, et al.Journal for Immunotherapy of Cancer|November 11, 2025
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumorsSheila Carrera-Justiz, Mahya Aghaee, Sadeem Qdaisat, et al.The Journal of Clinical Endocrinology and Metabolism|August 16, 2016
Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-SituAdeline K Nicholas, Eva G Serra, Hakan Cangul, et al.Nature Biomedical Engineering|July 18, 2025
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreadingSadeem Qdaisat, Brandon Wummer, Brian D Stover, et al.The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
mRNA aggregates harness danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.Pageof 91